The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Cancer research 2012 Nov 72 (22): 5683-91.
Serra Stefano, Zheng Lei, Hassan Manal, Phan Alexandria T, Woodhouse Linda J, Yao James C, Ezzat Shereen, Asa Sylvia
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: